American Board of Rheumatology Certification Exam

American Board of Rheumatology Rheumatology board candidates often misjudge drug metabolism timelines and overlook the distinction between seronegative and seropositive disease progression patterns. Many rush through differential diagnoses for overlap syndromes, conflating lupus manifestations with systemic sclerosis cutaneous features. Strong performance requires methodical case analysis and precise pharmacokinetic reasoning across immunosuppressant classes.